APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation Anesthetic

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Inhalation Anesthetic Market Outlook and Growth Opportunities 2026

30 December 2025196 pages

Choose your research edition.

Industry ResearchInhalation Anesthetic Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation Anesthetic Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Inhalation Anesthetic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation Anesthetic Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation Anesthetic Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Inhalation Anesthetic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Inhalation Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalation Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Inhalation Anesthetic market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Inhalation Anesthetic market include Mylan, Hengrui, Baxter Healthcare, AstraZeneca, Piramal Healthcare, Nhwa, Maruishi, Lunan and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhalation Anesthetic market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalation Anesthetic and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalation Anesthetic sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalation Anesthetic market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalation Anesthetic Segment by Company

Mylan

Hengrui

Baxter Healthcare

AstraZeneca

Piramal Healthcare

Nhwa

Maruishi

Lunan

Hikma Pharmaceuticals

Fresenius-Kabi

Deltasorb Technologies (Blue Zone Technology)

Braun

BbVie Laboratories

Anesthesia Reclamation

Inhalation Anesthetic Segment by Type

Desflurane

Sevoflurane

Isoflurane

Others

Inhalation Anesthetic Segment by Application

Hospital Use

Clinic Use

Inhalation Anesthetic Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Inhalation Anesthetic status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Inhalation Anesthetic market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Inhalation Anesthetic significant trends, drivers, influence factors in global and regions.

6. To analyze Inhalation Anesthetic competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Anesthetic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation Anesthetic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Anesthetic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhalation Anesthetic market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inhalation Anesthetic industry.

Chapter 3: Detailed analysis of Inhalation Anesthetic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Inhalation Anesthetic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Inhalation Anesthetic in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Inhalation Anesthetic Industry Trends Table 2. Inhalation Anesthetic Industry Drivers Table 3. Inhalation Anesthetic Industry Opportunities and Challenges Table 4. Inhalation Anesthetic Industry Restraints Table 5. Global Inhalation Anesthetic Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Inhalation Anesthetic Revenue Share by Company (2021-2026) Table 7. Global Inhalation Anesthetic Sales Volume by Company (W Tons) & (2021-2026) Table 8. Global Inhalation Anesthetic Sales Volume Share by Company (2021-2026) Table 9. Global Inhalation Anesthetic Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Inhalation Anesthetic Company Ranking, (2024-2026) & (USD Million) Table 11. Global Inhalation Anesthetic Key Company Manufacturing Base & Headquarters Table 12. Global Inhalation Anesthetic Company, Product Type & Application Table 13. Global Inhalation Anesthetic Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhalation Anesthetic by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Desflurane Table 18. Significant Companies of Sevoflurane Table 19. Significant Companies of Isoflurane Table 20. Significant Companies of Others Table 21. Global Inhalation Anesthetic Sales Volume by Type 2021 VS 2025 VS 2032 (W Tons) Table 22. Global Inhalation Anesthetic Sales Volume by Type (2021-2026) & (W Tons) Table 23. Global Inhalation Anesthetic Sales Volume by Type (2027-2032) & (W Tons) Table 24. Global Inhalation Anesthetic Sales Volume Share by Type (2021-2026) Table 25. Global Inhalation Anesthetic Sales Volume Share by Type (2027-2032) Table 26. Global Inhalation Anesthetic Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Inhalation Anesthetic Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Inhalation Anesthetic Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Inhalation Anesthetic Sales Value Share by Type (2021-2026) Table 30. Global Inhalation Anesthetic Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Use Table 32. Significant Companies of Clinic Use Table 33. Global Inhalation Anesthetic Sales Volume by Application 2021 VS 2025 VS 2032 (W Tons) Table 34. Global Inhalation Anesthetic Sales Volume by Application (2021-2026) & (W Tons) Table 35. Global Inhalation Anesthetic Sales Volume by Application (2027-2032) & (W Tons) Table 36. Global Inhalation Anesthetic Sales Volume Share by Application (2021-2026) Table 37. Global Inhalation Anesthetic Sales Volume Share by Application (2027-2032) Table 38. Global Inhalation Anesthetic Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Inhalation Anesthetic Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Inhalation Anesthetic Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Inhalation Anesthetic Sales Value Share by Application (2021-2026) Table 42. Global Inhalation Anesthetic Sales Value Share by Application (2027-2032) Table 43. Global Inhalation Anesthetic Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 44. Global Inhalation Anesthetic Sales by Region (2021-2026) & (W Tons) Table 45. Global Inhalation Anesthetic Sales Market Share by Region (2021-2026) Table 46. Global Inhalation Anesthetic Sales by Region (2027-2032) & (W Tons) Table 47. Global Inhalation Anesthetic Sales Market Share by Region (2027-2032) Table 48. Global Inhalation Anesthetic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Inhalation Anesthetic Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Inhalation Anesthetic Sales Value Share by Region (2021-2026) Table 51. Global Inhalation Anesthetic Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Inhalation Anesthetic Sales Value Share by Region (2027-2032) Table 53. Global Inhalation Anesthetic Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Inhalation Anesthetic Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Inhalation Anesthetic Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Table 56. Global Inhalation Anesthetic Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Inhalation Anesthetic Sales by Country (2021-2026) & (W Tons) Table 58. Global Inhalation Anesthetic Sales Market Share by Country (2021-2026) Table 59. Global Inhalation Anesthetic Sales by Country (2027-2032) & (W Tons) Table 60. Global Inhalation Anesthetic Sales Market Share by Country (2027-2032) Table 61. Global Inhalation Anesthetic Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Inhalation Anesthetic Sales Value Market Share by Country (2021-2026) Table 63. Global Inhalation Anesthetic Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Inhalation Anesthetic Sales Value Market Share by Country (2027-2032) Table 65. Mylan Company Information Table 66. Mylan Business Overview Table 67. Mylan Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Mylan Inhalation Anesthetic Product Portfolio Table 69. Mylan Recent Development Table 70. Hengrui Company Information Table 71. Hengrui Business Overview Table 72. Hengrui Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Hengrui Inhalation Anesthetic Product Portfolio Table 74. Hengrui Recent Development Table 75. Baxter Healthcare Company Information Table 76. Baxter Healthcare Business Overview Table 77. Baxter Healthcare Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Baxter Healthcare Inhalation Anesthetic Product Portfolio Table 79. Baxter Healthcare Recent Development Table 80. AstraZeneca Company Information Table 81. AstraZeneca Business Overview Table 82. AstraZeneca Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. AstraZeneca Inhalation Anesthetic Product Portfolio Table 84. AstraZeneca Recent Development Table 85. Piramal Healthcare Company Information Table 86. Piramal Healthcare Business Overview Table 87. Piramal Healthcare Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Piramal Healthcare Inhalation Anesthetic Product Portfolio Table 89. Piramal Healthcare Recent Development Table 90. Nhwa Company Information Table 91. Nhwa Business Overview Table 92. Nhwa Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Nhwa Inhalation Anesthetic Product Portfolio Table 94. Nhwa Recent Development Table 95. Maruishi Company Information Table 96. Maruishi Business Overview Table 97. Maruishi Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Maruishi Inhalation Anesthetic Product Portfolio Table 99. Maruishi Recent Development Table 100. Lunan Company Information Table 101. Lunan Business Overview Table 102. Lunan Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Lunan Inhalation Anesthetic Product Portfolio Table 104. Lunan Recent Development Table 105. Hikma Pharmaceuticals Company Information Table 106. Hikma Pharmaceuticals Business Overview Table 107. Hikma Pharmaceuticals Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Hikma Pharmaceuticals Inhalation Anesthetic Product Portfolio Table 109. Hikma Pharmaceuticals Recent Development Table 110. Fresenius-Kabi Company Information Table 111. Fresenius-Kabi Business Overview Table 112. Fresenius-Kabi Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. Fresenius-Kabi Inhalation Anesthetic Product Portfolio Table 114. Fresenius-Kabi Recent Development Table 115. Deltasorb Technologies (Blue Zone Technology) Company Information Table 116. Deltasorb Technologies (Blue Zone Technology) Business Overview Table 117. Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Product Portfolio Table 119. Deltasorb Technologies (Blue Zone Technology) Recent Development Table 120. Braun Company Information Table 121. Braun Business Overview Table 122. Braun Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. Braun Inhalation Anesthetic Product Portfolio Table 124. Braun Recent Development Table 125. BbVie Laboratories Company Information Table 126. BbVie Laboratories Business Overview Table 127. BbVie Laboratories Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. BbVie Laboratories Inhalation Anesthetic Product Portfolio Table 129. BbVie Laboratories Recent Development Table 130. Anesthesia Reclamation Company Information Table 131. Anesthesia Reclamation Business Overview Table 132. Anesthesia Reclamation Inhalation Anesthetic Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 133. Anesthesia Reclamation Inhalation Anesthetic Product Portfolio Table 134. Anesthesia Reclamation Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Inhalation Anesthetic Distributors List Table 138. Inhalation Anesthetic Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Inhalation Anesthetic Product Image Figure 2. Global Inhalation Anesthetic Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation Anesthetic Sales Value (2021-2032) & (US$ Million) Figure 4. Global Inhalation Anesthetic Sales (2021-2032) & (W Tons) Figure 5. Global Inhalation Anesthetic Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Inhalation Anesthetic Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Desflurane Image Figure 10. Sevoflurane Image Figure 11. Isoflurane Image Figure 12. Others Image Figure 13. Global Inhalation Anesthetic Sales Volume by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 14. Global Inhalation Anesthetic Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Inhalation Anesthetic Sales Volume Share by Type (2021-2032) Figure 16. Global Inhalation Anesthetic Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Inhalation Anesthetic Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Inhalation Anesthetic Sales Value Share by Type (2021-2032) Figure 19. Hospital Use Image Figure 20. Clinic Use Image Figure 21. Global Inhalation Anesthetic Sales Volume by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 22. Global Inhalation Anesthetic Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Inhalation Anesthetic Sales Volume Share by Application (2021-2032) Figure 24. Global Inhalation Anesthetic Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Inhalation Anesthetic Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Inhalation Anesthetic Sales Value Share by Application (2021-2032) Figure 27. Global Inhalation Anesthetic Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Figure 28. Global Inhalation Anesthetic Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Inhalation Anesthetic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Inhalation Anesthetic Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Inhalation Anesthetic Sales Value (2021-2032) & (US$ Million) Figure 32. North America Inhalation Anesthetic Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Inhalation Anesthetic Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Inhalation Anesthetic Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Inhalation Anesthetic Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Inhalation Anesthetic Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Inhalation Anesthetic Sales Value (2021-2032) & (US$ Million) Figure 38. South America Inhalation Anesthetic Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Inhalation Anesthetic Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Inhalation Anesthetic Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Inhalation Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Inhalation Anesthetic Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Inhalation Anesthetic Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Desflurane
  • Sevoflurane
  • Isoflurane
  • Others
Applications
  • Hospital Use
  • Clinic Use
Companies covered
  • Mylan
  • Hengrui
  • Baxter Healthcare
  • AstraZeneca
  • Piramal Healthcare
  • Nhwa
  • Maruishi
  • Lunan
  • Hikma Pharmaceuticals
  • Fresenius-Kabi
  • Deltasorb Technologies (Blue Zone Technology)
  • Braun
  • BbVie Laboratories
  • Anesthesia Reclamation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhalation Anesthetic Sales Value (2021-2032)
  4. 1.2.2 Global Inhalation Anesthetic Sales Volume (2021-2032)
  5. 1.2.3 Global Inhalation Anesthetic Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Inhalation Anesthetic Market Dynamics
  1. 2.1 Inhalation Anesthetic Industry Trends
  2. 2.2 Inhalation Anesthetic Industry Drivers
  3. 2.3 Inhalation Anesthetic Industry Opportunities and Challenges
  4. 2.4 Inhalation Anesthetic Industry Restraints
3 Inhalation Anesthetic Market by Company
  1. 3.1 Global Inhalation Anesthetic Company Revenue Ranking in 2025
  2. 3.2 Global Inhalation Anesthetic Revenue by Company (2021-2026)
  3. 3.3 Global Inhalation Anesthetic Sales Volume by Company (2021-2026)
  4. 3.4 Global Inhalation Anesthetic Average Price by Company (2021-2026)
  5. 3.5 Global Inhalation Anesthetic Company Ranking (2024-2026)
  6. 3.6 Global Inhalation Anesthetic Company Manufacturing Base and Headquarters
  7. 3.7 Global Inhalation Anesthetic Company Product Type and Application
  8. 3.8 Global Inhalation Anesthetic Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Inhalation Anesthetic Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Inhalation Anesthetic Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Inhalation Anesthetic Market by Type
  1. 4.1 Inhalation Anesthetic Type Introduction
  2. 4.1.1 Desflurane
  3. 4.1.2 Sevoflurane
  4. 4.1.3 Isoflurane
  5. 4.1.4 Others
  6. 4.2 Global Inhalation Anesthetic Sales Volume by Type
  7. 4.2.1 Global Inhalation Anesthetic Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Inhalation Anesthetic Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Inhalation Anesthetic Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Inhalation Anesthetic Sales Value by Type
  11. 4.3.1 Global Inhalation Anesthetic Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Inhalation Anesthetic Sales Value by Type (2021-2032)
  13. 4.3.3 Global Inhalation Anesthetic Sales Value Share by Type (2021-2032)
5 Inhalation Anesthetic Market by Application
  1. 5.1 Inhalation Anesthetic Application Introduction
  2. 5.1.1 Hospital Use
  3. 5.1.2 Clinic Use
  4. 5.2 Global Inhalation Anesthetic Sales Volume by Application
  5. 5.2.1 Global Inhalation Anesthetic Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Inhalation Anesthetic Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Inhalation Anesthetic Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Inhalation Anesthetic Sales Value by Application
  9. 5.3.1 Global Inhalation Anesthetic Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Inhalation Anesthetic Sales Value by Application (2021-2032)
  11. 5.3.3 Global Inhalation Anesthetic Sales Value Share by Application (2021-2032)
6 Inhalation Anesthetic Regional Sales and Value Analysis
  1. 6.1 Global Inhalation Anesthetic Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhalation Anesthetic Sales by Region (2021-2032)
  3. 6.2.1 Global Inhalation Anesthetic Sales by Region: 2021-2026
  4. 6.2.2 Global Inhalation Anesthetic Sales by Region (2027-2032)
  5. 6.3 Global Inhalation Anesthetic Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Inhalation Anesthetic Sales Value by Region (2021-2032)
  7. 6.4.1 Global Inhalation Anesthetic Sales Value by Region: 2021-2026
  8. 6.4.2 Global Inhalation Anesthetic Sales Value by Region (2027-2032)
  9. 6.5 Global Inhalation Anesthetic Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Inhalation Anesthetic Sales Value (2021-2032)
  12. 6.6.2 North America Inhalation Anesthetic Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Inhalation Anesthetic Sales Value (2021-2032)
  15. 6.7.2 Europe Inhalation Anesthetic Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Inhalation Anesthetic Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Inhalation Anesthetic Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Inhalation Anesthetic Sales Value (2021-2032)
  21. 6.9.2 South America Inhalation Anesthetic Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Inhalation Anesthetic Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Inhalation Anesthetic Sales Value Share by Country, 2025 VS 2032
7 Inhalation Anesthetic Country-level Sales and Value Analysis
  1. 7.1 Global Inhalation Anesthetic Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Inhalation Anesthetic Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Inhalation Anesthetic Sales by Country (2021-2032)
  4. 7.3.1 Global Inhalation Anesthetic Sales by Country (2021-2026)
  5. 7.3.2 Global Inhalation Anesthetic Sales by Country (2027-2032)
  6. 7.4 Global Inhalation Anesthetic Sales Value by Country (2021-2032)
  7. 7.4.1 Global Inhalation Anesthetic Sales Value by Country (2021-2026)
  8. 7.4.2 Global Inhalation Anesthetic Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Inhalation Anesthetic Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Inhalation Anesthetic Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Inhalation Anesthetic Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Mylan
  2. 8.1.1 Mylan Company Information
  3. 8.1.2 Mylan Business Overview
  4. 8.1.3 Mylan Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Mylan Inhalation Anesthetic Product Portfolio
  6. 8.1.5 Mylan Recent Developments
  7. 8.2 Hengrui
  8. 8.2.1 Hengrui Company Information
  9. 8.2.2 Hengrui Business Overview
  10. 8.2.3 Hengrui Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hengrui Inhalation Anesthetic Product Portfolio
  12. 8.2.5 Hengrui Recent Developments
  13. 8.3 Baxter Healthcare
  14. 8.3.1 Baxter Healthcare Company Information
  15. 8.3.2 Baxter Healthcare Business Overview
  16. 8.3.3 Baxter Healthcare Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Baxter Healthcare Inhalation Anesthetic Product Portfolio
  18. 8.3.5 Baxter Healthcare Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Inhalation Anesthetic Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Piramal Healthcare
  26. 8.5.1 Piramal Healthcare Company Information
  27. 8.5.2 Piramal Healthcare Business Overview
  28. 8.5.3 Piramal Healthcare Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Piramal Healthcare Inhalation Anesthetic Product Portfolio
  30. 8.5.5 Piramal Healthcare Recent Developments
  31. 8.6 Nhwa
  32. 8.6.1 Nhwa Company Information
  33. 8.6.2 Nhwa Business Overview
  34. 8.6.3 Nhwa Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nhwa Inhalation Anesthetic Product Portfolio
  36. 8.6.5 Nhwa Recent Developments
  37. 8.7 Maruishi
  38. 8.7.1 Maruishi Company Information
  39. 8.7.2 Maruishi Business Overview
  40. 8.7.3 Maruishi Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Maruishi Inhalation Anesthetic Product Portfolio
  42. 8.7.5 Maruishi Recent Developments
  43. 8.8 Lunan
  44. 8.8.1 Lunan Company Information
  45. 8.8.2 Lunan Business Overview
  46. 8.8.3 Lunan Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lunan Inhalation Anesthetic Product Portfolio
  48. 8.8.5 Lunan Recent Developments
  49. 8.9 Hikma Pharmaceuticals
  50. 8.9.1 Hikma Pharmaceuticals Company Information
  51. 8.9.2 Hikma Pharmaceuticals Business Overview
  52. 8.9.3 Hikma Pharmaceuticals Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hikma Pharmaceuticals Inhalation Anesthetic Product Portfolio
  54. 8.9.5 Hikma Pharmaceuticals Recent Developments
  55. 8.10 Fresenius-Kabi
  56. 8.10.1 Fresenius-Kabi Company Information
  57. 8.10.2 Fresenius-Kabi Business Overview
  58. 8.10.3 Fresenius-Kabi Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Fresenius-Kabi Inhalation Anesthetic Product Portfolio
  60. 8.10.5 Fresenius-Kabi Recent Developments
  61. 8.11 Deltasorb Technologies (Blue Zone Technology)
  62. 8.11.1 Deltasorb Technologies (Blue Zone Technology) Company Information
  63. 8.11.2 Deltasorb Technologies (Blue Zone Technology) Business Overview
  64. 8.11.3 Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Product Portfolio
  66. 8.11.5 Deltasorb Technologies (Blue Zone Technology) Recent Developments
  67. 8.12 Braun
  68. 8.12.1 Braun Company Information
  69. 8.12.2 Braun Business Overview
  70. 8.12.3 Braun Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Braun Inhalation Anesthetic Product Portfolio
  72. 8.12.5 Braun Recent Developments
  73. 8.13 BbVie Laboratories
  74. 8.13.1 BbVie Laboratories Company Information
  75. 8.13.2 BbVie Laboratories Business Overview
  76. 8.13.3 BbVie Laboratories Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 BbVie Laboratories Inhalation Anesthetic Product Portfolio
  78. 8.13.5 BbVie Laboratories Recent Developments
  79. 8.14 Anesthesia Reclamation
  80. 8.14.1 Anesthesia Reclamation Company Information
  81. 8.14.2 Anesthesia Reclamation Business Overview
  82. 8.14.3 Anesthesia Reclamation Inhalation Anesthetic Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Anesthesia Reclamation Inhalation Anesthetic Product Portfolio
  84. 8.14.5 Anesthesia Reclamation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhalation Anesthetic Value Chain Analysis
  2. 9.1.1 Inhalation Anesthetic Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhalation Anesthetic Sales Mode & Process
  6. 9.2 Inhalation Anesthetic Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhalation Anesthetic Distributors
  9. 9.2.3 Inhalation Anesthetic Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst